Alexander Christopher Jonathan van Akkooi

Has grant

Associate Professor

Melanoma Institute Australia

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Alexander Christopher Jonathan van Akkooi is an Associate Professor at the Melanoma Institute Australia. His research focuses on advanced melanoma treatments, including immune checkpoint inhibitors and novel surgical approaches. His recent publications address clinical outcomes in melanoma patients and guidelines for treatment and management strategies. He contributes to the advancement of knowledge in the field of melanoma through rigorous research and clinical practice.

Recent Grants

Grant: Close

Translational study moving towards logical and personal combination therapies in the treatment of melanoma in-transit metastases and improving understanding of underlying biology

Open Date: 2018-04-01

Close Date:

Grant: Close

Translational Research (TR) Project of the Reductor study (Cytoreductive treatment of Dabrafenib combined with Trametinib to allow complete surgical resection in patients with BRAF mutated, prior unresectable stage III or IV Melanoma).

Open Date: 2018-01-01

Close Date:

Grant: Close

Melanoma Stage III Registry

Open Date: 2017-01-01

Close Date:

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Jane Yuet Ching Hui

University of Minnesota

UNITED STATES

View details

Rebecca Lee

The University of Manchester

UNITED KINGDOM

View details

Serigne N. Lô

AUSTRALIA

View details

Brenda Leeneman

Assistant professor

Erasmus Universiteit Rotterdam Erasmus School of Health Policy and Management

NETHERLANDS

View details

Tina Hieken

Professor of Surgery

Mayo Clinic Minnesota

UNITED STATES

View details

Ann-Sophie Bohne

Universitätsklinikum Schleswig-Holstein Campus Kiel

GERMANY

View details

Margreet Franken

Assistant professor

Erasmus Universiteit Rotterdam Erasmus School of Health Policy and Management

NETHERLANDS

View details

Paul Lorigan

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alexander Christopher Jonathan van Akkooi

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma.

A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases

Clinical significance of intra-thoracic and intra-abdominal sentinel lymph nodes detected on lymphoscintigraphy in truncal melanoma patients

Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study

Comparison of clinicopathological features and treatment outcomes for cutaneous melanomas of the head and neck and melanomas arising at other sites: Implications for systemic therapy

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2024

External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsy

Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo

Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Adjuvant Therapy for Melanoma: Past, Current, and Future Developments

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs

Collaborators (8)

Jane Yuet Ching Hui

Rebecca Lee

Serigne N. Lô

Brenda Leeneman

Tina Hieken

Ann-Sophie Bohne

Margreet Franken

Paul Lorigan

Make your next move.